BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 803252)

  • 21. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
    Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
    [No Abstract]   [Full Text] [Related]  

  • 22. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
    Mauch PM; Weinstein H; Botnick L; Belli J; Cassady JR
    Cancer; 1983 Mar; 51(5):925-32. PubMed ID: 6687379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
    Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
    [No Abstract]   [Full Text] [Related]  

  • 24. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy of Hodgkin's disease.
    Nison DW; Aisenberg AC
    Cancer; 1974 Jun; 33(6):1499-504. PubMed ID: 4834147
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 27. The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial.
    Andrieu JM; Bayle-Weisgerber C; Boiron M; Briere JF; Clot P; Dana M; Jacquillat C; Katz M; Teillet F
    Eur J Cancer (1965); 1979 Feb; 15(2):153-61. PubMed ID: 374084
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
    Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
    NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
    Grozea PN; De Persio EJ; Coltman CA; Fabian CJ; Morrison FS; Gehan EA; Jones SE
    Recent Results Cancer Res; 1982; 80():83-91. PubMed ID: 6173904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent progress in the treatment of Hodgkin's disease].
    Jacquillat C
    Acquis Med Recent; 1977; ():89-98. PubMed ID: 910606
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA; Carter SK
    Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
    [No Abstract]   [Full Text] [Related]  

  • 33. Stages I--III Hodgkin's disease in children: results of staging and treatment.
    Botnick LE; Goodman R; Jaffe N; Filler R; Cassady JR
    Cancer; 1977 Feb; 39(2):599-603. PubMed ID: 402183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial.
    O'Connell MJ; Wiernik PH; Brace KC; Byhardt RW; Greene WH
    Cancer; 1975 Apr; 35(4):1055-65. PubMed ID: 1116100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.
    Weller SA; Glatstein E; Kaplan HS; Rosenberg SA
    Cancer; 1976 Jun; 37(6):2840-6. PubMed ID: 949704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy.
    Chisesi T; Ricciardi O; Dal Fior S; Cappellari F; Pozza F; Dini E
    Tumori; 1983 Oct; 69(5):455-61. PubMed ID: 6689093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
    Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G
    Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
    Frei E; Luce JK; Gamble JF; Coltman CA; Constanzi JJ; Talley RW; Monto RW; Wilson HE; Hewlett JS; Delaney FC; Gehan EA
    Ann Intern Med; 1973 Sep; 79(3):376-82. PubMed ID: 4748254
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of Hodgkin's and non-Hodgkin's lymphomas.
    Sahakian GJ
    Med Clin North Am; 1975 Mar; 59(2):387-97. PubMed ID: 1117771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.